US Patent 7105560 Use of etodolac in the treatment of multiple myeloma
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+266 characters)
Article
Patent abstract
A method of treating multiple myeloma (MM) is provided comprising administering an amount of etodolac to a subject afflicted with MM that is effective to selectively reduce the viability of and/or to sensitize the cancer cells to an anti-cancer agent.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07105560 Use of etodolac in the treatment of multiple myeloma US Patent 7105560 Use of etodolac in the treatment of multiple myeloma
Infobox
Patent Number
0710556000
Patent Number
710556000
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071055600
Date of Patent
September 12, 2006
0Patent Application Number
095894760
Date Filed
June 7, 2000
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071055600
Date of Patent
September 12, 2006
0Patent Application Number
095894760
Date Filed
June 7, 2000
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07105560 Use of etodolac in the treatment of multiple myeloma
Infobox
Is a
Patent jurisdiction
Patent number
07105560
Date of patent
September 12, 2006
Patent application number
09589476
Date Filed
June 7, 2000
Patent primary examiner
Find more entities like US Patent 7105560 Use of etodolac in the treatment of multiple myeloma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.